Pathophysiology of the heart in Chagas' disease: current status and new developments

Maria de Lourdes Higuchi1, Luiz Alberto Benvenuti, Marcia Martins Reis

  • 1Laboratory of Pathology, Heart Institute (InCor), University of Sao Paulo Medical School, Av. Dr. Enéas de Carvalho Aguiar 44, São Paulo (SP), 05403-000, Brazil. amplourdes@incor.usp.br

Cardiovascular Research
|October 3, 2003
PubMed

Insights

This review explores Chagas

Area of Science:

  • Pathology and immunology of infectious diseases.
  • Parasitology and host-pathogen interactions.

Background:

  • Chagas' disease (American trypanosomiasis) is a complex parasitic infection with significant histopathological and pathogenetic aspects.
  • Understanding the chronic cardiac manifestations and indeterminate forms is crucial for disease management.

Purpose of the Study:

  • To review historical and recent findings on Chagas' disease, focusing on histopathology and pathogenesis.
  • To propose a unified theory integrating diverse study findings.
  • To elucidate the mechanisms underlying chronic cardiac Chagas' disease.

Main Methods:

  • Comprehensive review of historical data on Chagas' disease studies.
  • Integration of recent discoveries utilizing advanced pathology and immunology technologies.
  • Analysis of host-parasite interactions and immune responses.

Main Results:

  • A unified theory is proposed linking histopathological findings, pathogenetic theories, and modern technological discoveries.
  • Chronic cardiac Chagas' disease results from host-parasite interaction, influenced by immune response efficiency.
  • Immune imbalance, triggered by deficient host immunity or high parasitemia, leads to inadequate immunological responses and progressive organ damage.

Conclusions:

  • The proposed unified theory offers a comprehensive framework for understanding Chagas' disease pathogenesis.
  • Recurrent inflammatory responses are implicated in progressive neuronal damage, microcirculatory alterations, and cardiac matrix deformation.
  • Understanding these mechanisms is key to addressing the organ failure seen in chronic Chagas' disease.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...